August 2013 – OneMedPlace

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO

August 29, 2013 Herina Ayot 0

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO […]

“Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities Exchange “Postponed”; Amarantus BioScience (AMBS) DTC Chill Lifted. What is the Next Step for Corporate Governance in the Biotechnology Sector?

August 6, 2013 OneMedPlace Team 0

Recent challenges to biotechnology companies have been in the form of corporate governance issues, especially those undergoing rapid growth. Two companies in particular, InVivo (NVIV) […]

“SEC’s A Crowd” SEC Finally Issues Determination on Internet-Based Crowdfunding Platforms. How Will This Affect Fundraising?

August 2, 2013 OneMedPlace Team 0

One of the major obstacles of growth for Internet based Crowdfunding platforms in the U.S. has been the reaction of regulatory authorities. However, two “no-action […]

OneMedPlace | Blog

Just another WordPress site

Month: August 2013

“InVivo Interim” InVivo (NVIV) President, CEO and CFO Frank Reynolds Resigns; Michael J. Astrue In As Interim CEO and Sean Moran in As Acting CFO

“Corporate Governance Gap” InVivo (NVIV) Delays Listing to National Securities Exchange “Postponed”; Amarantus BioScience (AMBS) DTC Chill Lifted. What is the Next Step for Corporate Governance in the Biotechnology Sector?

“SEC’s A Crowd” SEC Finally Issues Determination on Internet-Based Crowdfunding Platforms. How Will This Affect Fundraising?